Tesla shares (TSLA)

Key Updates

Tesla shares declined 2.70% to $382.81 since the March 25 report, reversing the previous session's gains and falling back below the $390 resistance level. The retreat reflects investor concerns over two critical developments: another delay in the Roadster unveiling to late April 2025 and the announcement of the capital-intensive Terafab chip manufacturing project launching in 7 days, which could push 2026 capex beyond $50 billion combined. Despite Bank of America's bullish stance maintaining a $460-$488 price target range, the stock remains under pressure with YTD losses expanding to -14.88% as free cash flow is projected to turn negative for the first time since 2018.

Current Trend

Tesla has established a clear downtrend in 2026, declining 14.88% YTD to $382.81, underperforming broader equity markets. The stock has failed to sustain momentum above the $390 resistance level, with the current 2.70% pullback confirming this technical barrier remains intact. Near-term price action shows consolidation between $380 support and $390 resistance, with the 1-month decline of 6.49% and 6-month decline of 13.08% indicating persistent selling pressure. The 5-day gain of 0.66% represents temporary stabilization rather than trend reversal, as the stock continues to trade within a bearish channel established since year-end 2025.

Investment Thesis

The investment thesis centers on Tesla's transformation from an electric vehicle manufacturer to an integrated AI and autonomous vehicle platform, with Wall Street analysts valuing the robotaxi business at $422-$735 billion—substantially exceeding the $345 billion attributed to traditional EV operations. The thesis requires successful execution across three capital-intensive initiatives: achieving 8.7 million FSD customers by 2030 from the current 1.1 million, scaling robotaxi operations from 2 cities to 9 by year-end 2026, and establishing in-house chip manufacturing through the Terafab project to support AI development. The company's ability to generate sufficient returns on the projected $50+ billion combined capex in 2026 while navigating regulatory approvals in China and Europe will determine whether the premium valuation assigned to autonomous technology materializes into shareholder value.

Thesis Status

The investment thesis faces near-term execution challenges as capital allocation pressures intensify. The Terafab announcement adds $30-$300 billion in potential capex requirements on top of the already elevated $20 billion baseline, raising concerns about capital efficiency and return timelines. The continued Roadster delays and planned discontinuation of Model S and Model X signal the company's strategic pivot away from traditional automotive products, but create near-term revenue headwinds. Positively, Bank of America's resumption of coverage with buy ratings and $460-$488 price targets validates the autonomous vehicle opportunity, with analysts assigning 54% of valuation to robotaxi versus 21% to core automotive. The thesis remains intact but requires flawless execution over the next 12-24 months as negative free cash flow materializes.

Key Drivers

The Terafab chip manufacturing initiative represents the most significant near-term catalyst, with launch scheduled in 7 days and CEO Musk stating current partners TSMC, Samsung, and Micron cannot meet future AI chip demand. UBS estimates initial capex of $30 billion with potential expansion to $300 billion at full capacity, targeting AI5 chip volume production in 2027. Robotaxi expansion continues as the primary growth driver, with Morgan Stanley forecasting 5 million units by 2035 and BofA projecting $1.58 cost per mile versus $3.41 for traditional ride-sharing. The company plans to expand from 2 cities currently to 9 by year-end 2026, though regulatory approvals in China and Europe remain uncertain. Traditional automotive operations face headwinds as the Roadster unveiling delays to late April 2025 and Model S/X discontinuation later this year redirect capacity toward robotaxi production beginning next month. Additional value drivers include the Optimus humanoid robot (valued at $30+ billion by BofA) expected to unveil third-generation by end of March 2025, and the energy division valued at $90 billion.

Technical Analysis

Tesla trades at $382.81, having failed to break above the $390 resistance level established in recent sessions. The stock retreated 2.70% from $393.45, confirming $390 as a critical technical barrier requiring sustained volume to overcome. Support remains at $380, tested multiple times over the past week, with a break below this level likely targeting the $371.53 low from March 20. The 14.88% YTD decline has established a downward channel, with lower highs at $450 (January) and $393 (March 25) defining the bearish structure. Short-term momentum indicators show consolidation between $380-$390, with the 5-day gain of 0.66% insufficient to signal trend reversal. Volume patterns during the recent 3.21% rally and subsequent 2.70% decline suggest institutional distribution rather than accumulation, as the stock fails to hold gains above resistance.

Bull Case

• Dominant Robotaxi Valuation: Bank of America values Tesla's autonomous vehicle and robotaxi businesses at $735 billion, more than double the $345 billion EV division, with projected cost advantage of $1.58 per mile versus $3.41 for traditional ride-sharing at scale. Source
• Market Share Leadership Potential: Wall Street analysts project Tesla could capture up to 50% of the global robotaxi market, with Morgan Stanley forecasting 5 million robotaxis on roads by 2035, establishing first-mover advantage in autonomous transportation. Source
• Vertical Integration Through Chip Manufacturing: The Terafab project launching in 7 days addresses critical supply constraints, with CEO Musk stating current partners cannot meet future AI chip demand, targeting AI5 chip volume production in 2027 for competitive advantage. Source
• Multiple Revenue Streams Beyond Automotive: Bank of America identifies additional value drivers including Optimus humanoid robot segment valued at over $30 billion and energy business valued at $90 billion, diversifying revenue beyond declining EV sales. Source
• Cost-Effective Autonomous Technology: Tesla's camera-only approach to autonomous driving is viewed as more cost-effective than competitors' multi-sensor systems, enabling more profitable scaling as the company expands from 2 cities to 9 by year-end 2026. Source

Bear Case

• Negative Free Cash Flow Projection: Wall Street analysts predict Tesla's free cash flow could turn negative for the first time since 2018, with expected negative FCF of $4.1 billion in 2026 as the company enters capital-intensive expansion phase with $20+ billion baseline capex plus Terafab costs. Source
• Excessive Capital Requirements: The Terafab chip manufacturing facility requires estimated $30 billion initially with potential expansion to $300 billion at full production capacity, creating significant execution risk and diluting returns on existing automotive and robotaxi investments. Source
• Low FSD Adoption Rate: Only 1.1 million of Tesla's 8.9 million vehicles sold have purchased FSD subscriptions (12.4% penetration), requiring aggressive growth to 8.7 million customers by 2030 for BofA's valuation model, with regulatory approval needed in China and Europe. Source
• Core Product Line Deterioration: Tesla plans to discontinue Model S and Model X later this year while the Roadster unveiling delays to late April 2025 mark another postponement for the vehicle originally scheduled for 2020, creating near-term revenue headwinds in traditional automotive. Source
• Limited Robotaxi Scale: Tesla currently operates ride-hailing services in only 2 cities with plans to expand to 9 by year-end 2026 and expects just 1,000 robotaxis on roads by end of 2026, representing minimal near-term revenue contribution despite premium valuation assigned to the business. Source